Abstract
An efficient route for the synthesis of novel 7-aryl and 7-spiropyrazolo[4\(^{\prime }\),3\(^{\prime }\):5,6]pyrido[2,3-d]pyrimidine derivatives is described. These compounds were obtained by a cyclocondensation reaction between pyrazolopyridinediamines 4 and aldehydes 5 or cyclic ketones 6 in the presence of acetic acid as catalyst. This procedure provides the desired compounds in good yields under a simple two-step methodology. The obtained compounds were evaluated as AChE inhibitors and showed weak AChe inhibition with \(\hbox {IC}_{50} = 115{-}470 \, \upmu \hbox {M}\).
Similar content being viewed by others
References
Rahmati A (2010) Synthesis of 4-aryl-3-methyl-6-oxo-4,5,6,7-tetrahydro-2\(H\)-pyrazolo[3,4-\(b\)]pyridine-5-carbonitrile via a one-pot, three-component reaction. Tetrahedron Lett 51:2967–2970. doi:10.1016/j.tetlet.2010.03.109
Shi DQ, Shi SH, Kim ZB, Huang S (2008) A novel and efficient one-pot synthesis of furo[3\(^{\prime }\),4\(^{\prime }\):5,6]pyrido[2,3-\(c\)]pyrazole derivatives using organocatalysts. Tetrahedron 64:2425–2432. doi:10.1016/j.tet.2007.12.053
Chebanov VA, Sakhno YI, Desenko VN (2007) Cyclocondensation reactions of 5-aminopyrazoles, pyruvic acids and aldehydes. Multicomponent approaches to pyrazolopyridines and related products. Tetrahedron 63:1229–1242. doi:10.1016/j.tet.2006.11.048
Nikpassand M, Mamaghani M, Tabatabaeian K (2009) An efficient one-pot three-component synthesis of fused 1,4-dihydropyridines using HY-zeolit. Molecules 14:1468–1474. doi:10.3390/molecules14041468
Quiroga J, Cruz S, Insuasty B, Abonia R, Nogueras M, Cobo J (2006) Three-component synthesis of hexahydropyridopyrimidine-spirocyclohexanetriones induced by microwave. Tetrahedron Lett 47:27–30. doi:10.1016/j.tetlet.2005.10.120
Mont N, Teixido J, Borrell J, Kappeb O (2003) A three-component synthesis of pyrido[2,3-\(d\)]pyrimidines. Tetrahedron Lett 44:5385–5387. doi:10.1016/S0040-4039(03)01306-6
Kappe CO (1993) 100 year of the Biginelli dihydropyrimidine synthesis. Tetrahedron 49:6937–6963. doi:10.1016/S0040-4020(01)87971-0
Hassan Hilmy KM, Khalifa MMA, Allah Hawata MA, AboAlzeen Keshk RM, El-Torgman A (2010) Synthesis of new pyrrolo[2,3-\(d\)]pyrimidine derivatives as antibacterial and antifungal agents. Eur J Med Chem 45:5243–5250. doi:10.1016/j.ejmech.2010.08.043
Aliaga MJ, Ramon DJ, Yus M (2010) Impregnated copper on magnetite: an efficient and green catalyst for the multicomponent preparation of propargylamines under solvent free conditions. Org Biomol Chem 8:43–49. doi:10.1039/B917923B
Kanth SR, Reddy GV, Kishore KH, Rao PS, Narsaiah B, Murthy US (2006) Convenient synthesis of novel 4-substitutedamino-5-trifluoromethyl-2,7-disubstituted pyrido[2,3-\(d\)] pyrimidines and their antibacterial activity. Eur J Med Chem 41:1011–1020. doi:10.1016/j.ejmech.2006.03.028
Edupuganti R, Wang Q, Tavares CDJ, Chitjian CA, Bachman JL, Ren P, Anslyn EV, Dalby LKN (2014) Synthesis and biological evaluation of pyrido[2,3-\(d\)]pyrimidine-2,4-dione derivatives as eEF-2K inhibitors. Bioorg Med Chem 22:4910–4916. doi:10.1016/j.bmc.2014.06.050
Heber D, Heers C, Ravens U (1993) Positive inotropic activity of 5-amino-6-cyano-1,3-dimethyl-1,2,3,4-tetrahydropyrido[2,3-\(d\)]pyrim idine-2,4-dione in cardiac muscle from guinea-pig and man. Part 6: compounds with positive inotropic activity. Pharmazie 48:537–541
Quintela M, Peinador C, Botana L, Estevez M, Riguera R (1997) Synthesis and antihistaminic activity of 2-guanadino-3-cyanopyridines and pyrido[2,3\(-d\)]-pyrimidines. Bioorg Med Chem 5:543–1553. doi:10.1016/S0968-0896(97)00108-9
Huang H, Hutta DA, Rinker JM, Hu H, Parsons WH, Schubert C, DesJarlais RL, Crysler CS, Chaikin MA, Donatelli RR, Chen Y, Cheng D, Zhou Z, Yurkow E, Manthey CL, Player MR (2009) Pyrido[2,3-\(d\)]pyrimidin-5-ones: a novel class of antiinflammatory macrophage colony-stimulating factor-1 receptor inhibitors. J Med Chem 52:1081–1099. doi:10.1021/jm801406h
Hayallah AM, Abdel-Hamid MK (2014) Design and synthesis of new pyrido[2,3-\(d\)]pyrimidine-1,4-dione derivatives as anti-inflammatory agents. Der Pharma Chem 6:45–57
Hasan MF, Madkour AM, Saleem I, Rahman JMA, Mohammed EAZ (1994) Reactions of 5-(\(p\)-Anisyl)-2-methyl-7-(\(p\)-tolyl)-4\(H\)-pyrido[2,3-\(d\)][1,3]oxazin-4-one. Heterocycles 38:57–69. doi:10.3987/COM-91-5873
Gangjee A, Vasudevan A, Queener SF, Kisliuk RL (1996) 2,4-diamino-5-deaza-6-substituted pyrido[2,3-\(d\)]pyrimidine antifolates as potent and selective nonclassical inhibitors of dihydrofolate reductases. J Med Chem 39:1438–1446. doi:10.1021/jm950786p
Kots AY, Choi BK, Estrella-Jimenez ME, Warren CA, Gilbertson SR, Guerrant RL, Murad F (2008) A chemical method for fast and sensitive detection of DNA synthesis in vivo. P Natl Acad Sci USA 105:8440–8845. doi:10.1073/pnas.0712168105
VanderWel SN, Harvey PJ, McNamara DJ, Repine JT, Keller PR, Quin J, Booth RJ, Elliott WL, Dobrusin EM, Fry DW, Toogood PL (2005) Pyrido[2,3-\(d\)]pyrimidin-7-ones as specific inhibitors of cyclin-dependent kinase 4. J Med Chem 48:2371–2387. doi:10.1021/jm049355
Dorsey JF, Jove R, Kraker AJ, Wu J (2000) The pyrido[2,3-\(d\)]pyrimidine derivative PD180970 Inhibits p210\(^{Bcr-Abl}\) tyrosine kinase and induces apoptosis of K562 Leukemic Cells. Cancer Res 60:3127–3131
Dea K, Bhaumikb A, Banerjeeb B, Mukhopadhyaya C (2015) An expeditious and efficient synthesis of spiro-pyrazolo[3,4-\(b\)]pyridines catalysed by recyclable mesoporous aluminosilicate nanoparticles in aqueous-ethanol. Tetrahedron Lett 56:1614–1618. doi:10.1016/j.tetlet.2015.01.163
Quiroga J, Trilleras J, Pantoja D, Abonía R, Insuasty B, Nogueras M, Cobo J (2010) Microwave-assisted synthesis of pyrazolo[3,4-\(b\)]pyridine-spirocycloalkanediones by three-component reaction of 5-aminopyrazole derivatives, paraformaldehyde and cyclic \(\beta \)-diketones. Tetrahedron Lett 51:4717–4719. doi:10.1016/j.tetlet.2010.07.009
Tsolaki M, Kokarida K, Iakovidou V, Stilopoulos E, Meimaris J, Kazis A (2001) Extrapyramidal symptoms and signs in Alzheimer’s disease: pravalence and correlation with the first symptom. Am J Alzheimers Dis Other Demen 16:268–278. doi:10.1177/153331750101600512
Wimo A, Jönsson L, Gustavsson A, McDaid D, Ersek K, Georges J, Gulacsi L, Karpati K, Kenigsberg P, Valtonen H (2011) The economic impact of dementia in Europe in 2008-cost estimates from the Eurocode project. Int J Geriatr Ps 26:825–832. doi:10.1002/gps.2610
Francis PT, Palmer AM, Snape M, Wilcock GK (1999) The cholinergic hypothesis of Alzheimer’s disease: a review of progress. J Neurol Neurosur Ps 66:137–147. doi:10.1136/jnnp.66.2.137
Silva D, Chioua M, Samadi A, Carreiras MC, Jimeno ML, Mendes E, De los Ríos D, Romero A, Villarroya M, López MG, Marco-Contelles J (2011) Synthesis and pharmacological assessment of diversely substituted pyrazolo[3,4-\(b\)]quinoline, and benzo[\(b\)]pyrazolo[4,3-\(g\)][1,8]naphthyridine derivatives. Eur J Med Chem 46:4676–4681. doi:10.1016/j.ejmech.2011.05.068
Hameed A, Zehra ST, Shah SJA, Khan KM, Alharthy RD, Furtmann N, Bajorath J, Tahir MN, Iqbal J (2015) Syntheses, cholinesterases inhibition, and molecular docking studies of pyrido[2,3-\(b\)]pyrazine derivatives. Chem Biol Drug Des 86:1115–1120. doi:10.1111/cbdd.12579
Eliezer J, Barreiro EJ, Camara CA, Verli H, Brazil-Mas L, Castro NG, Cintra WM, Aracava Y, Rodrigues CR, Fraga CAM (2003) Design, synthesis, and pharmacological profile of novel fused pyrazolo[4,3-\(d\)]pyridine and pyrazolo[3,4-\(b\)][1,8]naphthyridine isosteres: a new class of potent and selective acetylcholinesterase inhibitors. J Med Chem 46:1144–1152. doi:10.1021/jm020391n
Romdhane A, Said AB, Cherif M, Jannet HB (2016) Design, synthesis and anti-cholinesterase evaluation of some new pyrazolo[4,3-\(e\)] -triazolo[1,5-\(c\)]pyrimidine derivatives. Med Chem Res 25:1358–1368. doi:10.1007/s00044-016-1576-0
Quiroga J, Alvarado M, Insuasty B, Moreno R (1999) Synthesis of 5-cyanopyrazolo[3,4-\(b\)]pyridines in the reaction of 5-amino-3-methyl-1-phenylpyrazole with arylidene derivatives of malonodinitrile and ethyl cyanoacetate. J Heterocycl Chem 36:1311–1316. doi:10.1002/jhet.5570360533
Quiroga J, Alvarado M, Insuasty B, Nogueras M, Sanchez A, Cobo J (1998) Synthesis of 6-cyanopyrido[2,3-\(d\)]pyrimidinones in the reaction of 6-amino-4-pyrimidinones with arylidene derivatives of malonodinitrile. J Heterocycl Chem 35:1309–1311. doi:10.1002/jhet.5570350612
Meerpoel L, Gestel J, Van Gerven F, Woestenborghs F, Marichal P, Sipido V, Terence V, Nash R, Corensa D, Richards R (2005) Pyrrolo[1,2-\(a\)][1,4]benzodiazepine: a novel class of non-azole anti-dermatophyte anti-fungal agents. Bioorg Med Chem 15:3453–3458. doi:10.1016/j.bmcl.2005.05.007
Acosta P, Insuasty B, Abonia R, Quiroga J (2015) Anellation of pyrrolo[1,2-\(a\)]pyrimidine and pyrido[1,2-\(a\)]pyrimidine systems to a pyrazolopyridine framework by a cascade of two cyclization reactions. Tetrahedron Lett 56:2917–2921. doi:10.1016/j.tetlet.2015.04.068
Barreiro EJ, Camara CA, Verli H, Brazil-Mas L, Castro NG, Cintra WM, Aracava Y, Rodrigues CR, Fraga CA (2003) Design, synthesis and pharmacological profile of novel fused pyrazolo[4,3-d]pyridine and pyrazolo[3,4-\(b\)][1,8]naphthyridine isoteres: a new class of potent and selective acetylcholinesterase inhibitors. J Med Chem 46:1144–1152. doi:10.1021/jm020391n
Gutiérrez M, Matus MF, Poblete T, Amigo J, Vallejos G, Astudillo L (2013) Isoxazoles: synthesis, evaluation and bioinformatic design as acetylcholinesterase inhibitors. J Pharm Pharmacol 65:1796–1804. doi:10.1111/jphp.12180
Ellman GL, Courtney KD, Andres V, Feather-Stone RM (1961) A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem Pharmacol 7:88–95. doi:10.1016/0006-2952(61)90145-9
Acknowledgements
Authors wish to thank the COLCIENCIAS and Universidad del Valle for financial support and to FONDECYT project number 1150712, PIEI QUIMBIO, project, Utalca, for financial support.
Author information
Authors and Affiliations
Corresponding author
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Acosta, P., Insuasty, B., Abonia, R. et al. Synthesis of novel 7-aryl and 7-spiropyrazolo[4′,3′:5,6]pyrido[2,3-d]pyrimidine derivatives and their study as AChE inhibitors. Mol Divers 21, 943–955 (2017). https://doi.org/10.1007/s11030-017-9774-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11030-017-9774-3